Sunshine Biopharma Receives Canadian Regulatory Approval for Enalapril, Expanding Into $25.94 Billion Global Anti-Hypertensive Drug Market
Go back to Sunshine Biopharma Receives Canadian Regulatory Approval for Enalapril, Expanding Into $25.94 Billion Global Anti-Hypertensive Drug Market| Sunshine Biopharma, Inc. (NASDAQ: SBFM) | Delayed: 1.15 +0.01 (0.88%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.14 | 52 Week High | $0.04 | |||
| Open | $1.18 | 52 Week Low | $0.00 | |||
| Day High | $1.24 | P/E | N/A | |||
| Day Low | $1.14 | EPS | $0.00 | |||
| Volume | 287,755 | |||||
